Sleep Medicine and Biology Division, Psychobiology Department, Universidade Federal de São Paulo, São Paulo, Brasil.
J Bras Pneumol. 2010 Jul-Aug;36(4):498-505. doi: 10.1590/s1806-37132010000400017.
Recent years have seen a growing interest in the use of portable monitoring devices for the diagnosis of obstructive sleep apnea syndrome. These have the potential to be used in lieu of the more complicated and uncomfortable alternative, polysomnography, which has long been considered to be the gold standard for the diagnosis of this relatively prevalent condition. Following their approval in 2008 by the Center of Medicare and Medicaid Services, the federal agency which administers Medicare and Medicaid in the United States, there has been extensive discussion about the utility and validity of these devices for use in the diagnosis of obstructive sleep apnea syndrome. Although there are various models of portable monitoring devices, the literature contains little information regarding how each device should be used in specific age groups, patients presenting comorbidities, and asymptomatic patients. Additionally, studies about the cost-effectiveness of this diagnostic method are scarce and conflicting. Therefore, this objective of this study was to review what has been learned about portable monitoring devices over time, as well as to examine the recent progress, advantages, limitations, and applications of these devices in the diagnosis of obstructive sleep apnea syndrome in different groups of patients.
近年来，人们对使用便携式监测设备来诊断阻塞性睡眠呼吸暂停综合征越来越感兴趣。这些设备有可能替代更为复杂和不适的多导睡眠图（polysomnography），后者长期以来一直被认为是诊断这种相对普遍疾病的金标准。自 2008 年美国医疗保险和医疗补助服务中心（Center of Medicare and Medicaid Services）批准这些设备以来，人们就广泛讨论了这些设备在诊断阻塞性睡眠呼吸暂停综合征中的实用性和有效性。尽管有各种型号的便携式监测设备，但文献中关于如何在特定年龄段、患有合并症的患者和无症状患者中使用每种设备的信息却很少。此外，关于这种诊断方法的成本效益的研究也很少且相互矛盾。因此，本研究的目的是回顾随着时间的推移对便携式监测设备的了解，以及检查这些设备在诊断不同患者群体的阻塞性睡眠呼吸暂停综合征方面的最新进展、优势、局限性和应用。
